The FDA's top regulator of cancer drugs interceded in a review of a Replimune skin cancer therapy, contributing to its ...

The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ label warning ...

The prelude to a transplant. A pause before a treatment plan can proceed. For every person in it, the waiting demands a balance between holding on and letting go.

The FDA's top regulator of cancer drugs played a key role in the rejection of a skin cancer therapy from Replimune Group, ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Many San Diego biotech firms are struggling to raise money, with the uncertainty exacerbated by the Trump administration’s ...

I understand the heartbreak of watching someone you love spiral. But compassion cannot mean locking people up,” writes a STAT ...

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

If you’ve followed health insurance earnings lately, you might be experiencing some whiplash. But some lessons about the ...

The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning ...

In a striking bipartisan move, the Senate Appropriations Committee voted 26-3 to boost the NIH’s budget by $400 million — rejecting the Trump administration’s proposed $17 billion cut and sweeping ...

President Trump escalated his demands that pharma firms lower U.S. prices in line with what other countries pay, sending ...